Exit Options for John Hancock Bond and Corporate Finance Group: Hanover Communications In... - 28 Strategic Investors

View x

Featured Sell side Propositions

  • 90% leased warehouse building - 460,000 sft. on 20 acres in Winnipeg, MB
    user photo
    BB0015514 (RE Seller)
    Location
    Winnipeg, MB, Canada
    Type
    Industrial
    Deal size
    Unpriced
    The property is located in close proximity to major traffic arteries and is currently generating annual rental income of CAD 2...
  • Off-market commercial building in Rome available from the seizing bank
    user photo
    BB0010484 (RE Seller)
    Location
    Via Tiburtina, Roma, Italy
    Type
    Office
    Deal size
    US$ 30M
    The 212,000-sft office building is leased to a large corporate and generating NOI of around $2.2M. It is available at a discou...
  • A 30-yr old Indian manufacturing co. with $46M/$10M rev/EBITDA, for sale
    user photo
    BB0012496 (M&A Seller)
    Region
    India
    Sector
    Capital Goods
    Revenue
    US$ 46M
    EBITDA
    US$ 10M
    Existing capacity is enough to double revenues without any major incremental investment. Over 90% of the sales are exports to ...
  • MBO of a European gaming and betting company with $180M/$33M Revenue/EBITDA.
    user photo
    BB001475 (Seeker)
    Region
    Italy
    Sector
    Consumer Services
    Deal size
    US$25M - 80M
    Management and current shareholders of the business want to spin-out the Italian business in exchange of USD83M.
  • A 50+ year old Spanish auto component company with $25M in revenues, for sale.
    user photo
    BB0012264 (M&A Seller)
    Region
    Spain
    Sector
    Automobiles & Components
    Revenue
    US$ 23M
    EBITDA
    US$ 5M
    A Tier 1 supplier with a diverse clientele base and consistent sales growth for the period 2013-2017.
  • Indian OTC pharma company with USD25M revenue, seeking USD15M of growth capital.
    user photo
    BB0012271 (Seeker)
    Region
    Central African, India
    Sector
    Pharmaceuticals, Biotechnology & Life Sciences
    Deal size
    US$15M - 20M
    Export focused pharmaceutical company seeking USD15mn for product development, product registration and working capital.